Multiple risk factors and ischaemic stroke in the elderly Asian population with and without atrial fibrillation

 

 Buy Article Permissions and Reprints

Summary

Ischaemic stroke risk rises with the increasing cardiovascular risk factors. How atrial fibrillation (AF) incrementally contributes to the risk for ischaemic stroke with increasing age and multiple cardiovascular risk factors is unclear. In an individual patient with AF the mechanism of ischaemic stroke may be related directly to AF itself or to risk factors associated with AF. It was this study’s objective to investigate incident ischaemic stroke in relation to age and increasing cardiovascular risk factor(s), and the incremental impact of AF on stroke rates. We studied a 5 % random sampling from Chinese medical insurance data covering more than 10 million individuals, for the years 2001 to 2012. The rate of ischaemic stroke was calculated amongst the individuals with no prior history of ischaemic stroke, in relation to age groups (aged < 65, 65–74,75 years old; n = 348,431, n = 56,952, n = 20,217, respectively), and increasing risk factors using the CHA₂DS₂-VASc score. Among the randomly sampled 425,600 individuals with total follow-up of 1,864,232 patient-years [63.8 % male, mean age 60 years; 880 with AF, vs 424,720 non-AF], there were 13,242 (3.1 %) ischaemic strokes after 64,834 person-years follow-up. Overall, ischaemic stroke incidence (per 100 person-years) was 0.35 (95 %CI 0.34–0.35) in the non-AF population and 1.11 (0.84–1.45) with AF. The AF population age < 65 and 65–74 had higher CHA₂DS₂-VASc scores than the nonAF population (p< 0.001), but this was non-significant between the non-AF and AF population age75 (p=0.086). For the population age75 years, incident stroke rates were 2.07 (0.86–4.76) and 4.29 (4.08–4.51) in non-AF and AF populations, respectively. The non-AF population age65 years with2 additional comorbidities (hyper-tension, vascular disease, diabetic, or heart failure) had ischaemic stroke rates similar to an AF population with CHA₂DS₂-VASc4. In both non-AF and AF populations, those with CHA₂DS₂-VASc =1 had a 1.9 fold increase in stroke risk, and those with CHA₂DS₂-VASc₂ had more than four-fold increased risk for stroke, compared with those with CHA₂DS₂-VASc=0. In conclusion, an increasing cluster of multiple cardiovascular risk factors (besides AF) contributes to a greater risk for ischaemic stroke, especially in the elderly population. If elderly and with multiple risk factors, non-AF patients may have a risk of incident ischaemic stroke that is comparable or even higher than patients with AF, suggesting that the incremental stroke risk attributable to AF is marginal in such ‘high risk’ patients.

^* Joint senior authors.

• References

• 1 Go AS, Mozaffarian D, Roger VL. et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee.. Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation 2014; 129: e28-e292.
  CrossrefPubMedGoogle Scholar
• 2 Meschia JF, Bushnell C, Boden-Albala B. et al. American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, Council on Functional Genomics and Translational Biology, and Council on Hypertension.. Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American heart association/American. Stroke Association. Stroke 2014; 45: 3754-3832.
  CrossrefPubMedGoogle Scholar
• 3 Rodgers H, Greenaway J, Davies T. et al. Risk factors for first-ever stroke in older people in the north East of England: a population-based study. Stroke 2004; 35: 7-11.
  PubMedGoogle Scholar
• 4 Feigin VL, Lawes CM, Bennett DA. et al. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol 2009; 08: 355-369.
  CrossrefPubMedGoogle Scholar
• 5 Kim JS. Stroke in Asia: a global disaster. Int J Stroke 2014; 09: 856-857.
  CrossrefPubMedGoogle Scholar
• 6 Feigin VL. Stroke epidemiology in the developing world. Lancet 2005; 365: 2160-2161.
  CrossrefPubMedGoogle Scholar
• 7 Hachinski V, Donnan GA, Gorelick PB. et al. Stroke: working toward a prioritized world agenda. Int J Stroke 2010; 05: 238-256.
  CrossrefPubMedGoogle Scholar
• 8 January CT, Wann LS, Alpert JS. et al. 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2014; 64: e1-e76.
  CrossrefPubMedGoogle Scholar
• 9 Camm AJ, Lip GY, De Caterina R. et al. ESC Committee for Practice Guidelines (CPG).2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation.. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 2012; 33: 2719-2747.
  CrossrefPubMedGoogle Scholar
• 10 Friberg L, Rosenqvist M, Lip GY. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. Eur Heart J 2012; 33: 1500-1510.
  CrossrefPubMedGoogle Scholar
• 11 Zhu WG, Xiong QM, Hong K. Meta-Analysis of CHADS2 versus CHA2DS2-VASc for Predicting Stroke and Thromboembolism in Atrial Fibrillation Patients Independent of Anticoagulation. Tex Heart Inst J 2015; 42: 6-15.
  PubMedGoogle Scholar
• 12 Guo Y, Apostolakis S, Blann AD. et al. Validation of contemporary stroke and bleeding risk stratification scores in non-anticoagulated Chinese patients with atrial fibrillation. Int J Cardiol 2013; 168: 904-909.
  CrossrefPubMedGoogle Scholar
• 13 Lip GY, Lin HJ, Chien KL. et al. Comparative assessment of published atrial fibrillation stroke risk stratification schemes for predicting stroke, in a non-atrial fibrillation population: the Chin-Shan Community Cohort Study. Int J Cardiol 2013; 168: 414-419.
  CrossrefPubMedGoogle Scholar
• 14 Chan YH, Yiu KH, Lau KK. et al. The CHADS2 and CHA2DS2-VASc scores predict adverse vascular function, ischaemic stroke and cardiovascular death in high-risk patients without atrial fibrillation: Role of incorporating PR prolongation. Atherosclerosis 2014; 237: 504-513.
  CrossrefPubMedGoogle Scholar
• 15 Chua SK, Lo HM, Chiu CZ. et al. Use of CHADS2 and CHA2DS2-VASc Scores to Predict Subsequent Myocardial Infarction, Stroke, and Death in Patients with Acute Coronary Syndrome: Data from Taiwan Acute Coronary Syndrome Full Spectrum Registry. PLoS One 2014; 09: e111167.
  CrossrefPubMedGoogle Scholar
• 16 Potpara TS, Polovina MM, Djikic D. et al. The association of CHA2DS2-VASc score and blood biomarkers with ischaemic stroke outcomes: the Belgrade stroke study. PLoS One 2014; 09: e106439.
  CrossrefPubMedGoogle Scholar
• 17 Guo Y, Tian Y, Wang H. et al. Prevalence, incidence and lifetime risk of atrial fibrillation in China: New insights into the global burden of atrial fibrillation. Chest. 2014 Epub ahead of print.
  PubMedGoogle Scholar
• 18 Im AJ, Fincke G, Berlowitz DR. et al. Comprehensive health status assessment of centenarians: results from the 1999 large health survey of veteran enrollees. J Gerontol A Biol Sci Med Sci 2005; 60: 515-519.
  CrossrefPubMedGoogle Scholar
• 19 Lochner KA, Cox CS. Prevalence of multiple chronic conditions among Medicare beneficiaries, United States, 2010. Prev Chronic Dis 2013; 10: E61.
  PubMedGoogle Scholar
• 20 Arnett DK, Goodman RA, Halperin JL. et al. AHA/ACC/HHS Strategies to Enhance Application of Clinical Practice Guidelines in Patients With Cardiovascular Disease and Comorbid Conditions: From the American Heart Association, American College of Cardiology, and U. S. Department of Health and Human Services. J Am Coll Cardiol 2014; 64: 1851-1856.
  CrossrefPubMedGoogle Scholar
• 21 Tsai CF, Thomas B, Sudlow CL. Epidemiology of stroke and its subtypes in Chinese vs white populations: a systematic review. Neurology 2013; 81: 264-272.
  CrossrefPubMedGoogle Scholar
• 22 Zhao D, Liu J, Wang W. et al. Epidemiological transition of stroke in China: twenty-one-year observational study from the Sino-MONICA-Beijing Project. Stroke 2008; 39: 1668-1674.
  CrossrefPubMedGoogle Scholar
• 23 Kernan WN, Ovbiagele B, Black HR. et al. American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Peripheral Vascular Disease.. Guidelines for the prevention of stroke in patients with stroke and transient ischaemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014; 45: 2160-2236.
  CrossrefPubMedGoogle Scholar
• 24 Fang MC, Coca Perraillon M, Ghosh K. et al. Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008. Am J Med 2014; 127: 608-615.
  CrossrefPubMedGoogle Scholar
• 25 Hyun KK, Huxley RR, Arima H. et al. A comparative analysis of risk factors and stroke risk for Asian and non-Asian men: the Asia Pacific cohort studies collaboration. Int J Stroke 2013; 08: 606-611.
  CrossrefPubMedGoogle Scholar
• 26 Kumamaru H, Judd SE, Curtis JR. et al. Validity of claims-based stroke algorithms in contemporary Medicare data: reasons for geographic and racial differences in stroke (REGARDS) study linked with medicare claims. Circ Cardiovasc Qual Outcomes 2014; 07: 611-619.
  CrossrefPubMedGoogle Scholar
• 27 Lowres N, Neubeck L, Redfern J. et al. Screening to identify unknown atrial fibrillation. A systematic review. Thromb Haemost 2013; 110: 213-222.
  Article in Thieme ConnectPubMedGoogle Scholar
• 28 Lowres N, Neubeck L, Salkeld G. et al. Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF study. Thromb Haemost 2014; 111: 1167-1176.
  Article in Thieme ConnectPubMedGoogle Scholar